LAUNXP Biomedical Co., Ltd
6876
Rank in Stocks
#25094
LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical... LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical treatments for various types of cancer. Their product line includes therapies designed to combat tumor growth and inhibit cell proliferation, notably utilizing advanced platforms such as virus-like nanoparticles and other nanoparticle-based drug delivery systems. The company was established on September 24, 2015, and its primary corporate operations are based in Taichung, Taiwan.
Share Price
$0.40696752
Last synced: 2026-11-10
Market Cap
$28.30M
Change (1 day)
-4.64%
Change (1 year)
-45.40%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade LAUNXP Biomedical Co., Ltd (6876)
Category
Healthcare
EPS for LAUNXP Biomedical Co., Ltd (6876)
EPS as of June 2026 TTM: $-0.24
According to LAUNXP Biomedical Co., Ltd's latest financial reports, its current EPS (TTM) is $-0.24. At the end of 2025 the company had an EPS of $-0.09, an increase over its 2024 EPS of $-0.11.
EPS history for LAUNXP Biomedical Co., Ltd from 2020 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.24 | 171.00% |
| 2025 | $-0.09 | -17.12% |
| 2024 | $-0.11 | -4.64% |
| 2023 | $-0.11 | 42.08% |
| 2022 | $-0.08 | 6.19% |
| 2021 | $-0.07 | -21.79% |
| 2020 | $-0.10 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -6,520.66% |
US
|
|
| $-7.07 | 2,798.73% |
US
|
|
| $-5.29 | 2,068.92% |
AU
|
|
| $12.88 | -5,380.89% |
BE
|
|
| $21.56 | -8,939.69% |
NL
|
Questions about LAUNXP Biomedical Co., Ltd's earnings per share (EPS)
What is LAUNXP Biomedical Co., Ltd's earnings per share (EPS)?
LAUNXP Biomedical Co., Ltd's earnings per share (EPS) over the last twelve months is $-0.24, as of Jun 2026.
What was LAUNXP Biomedical Co., Ltd's earnings per share (EPS) in 2025?
In 2025, LAUNXP Biomedical Co., Ltd's earnings per share (EPS) was $-0.09, compared with $-0.11 in 2024.
How has LAUNXP Biomedical Co., Ltd's earnings per share (EPS) changed since 2020?
From 2020 to 2025, LAUNXP Biomedical Co., Ltd's earnings per share (EPS) was highest in 2021 ($-0.07) and lowest in 2024 ($-0.11).
How does LAUNXP Biomedical Co., Ltd's earnings per share (EPS) compare with similar companies?
LAUNXP Biomedical Co., Ltd's earnings per share (EPS) ($-0.24) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.